What are the opening hours?

Monday 8am - 5pm Tuesday 8am - 5pm Wednesday 8am - 5pm Thursday 8am - 5pm Friday 8am - 5pm

ImpediMed

The world leader in the development and distribution of medical devices utilizing bioimpedance spectroscopy (BIS).

02/27/2026

“We have precision oncology, precision drugs, and tailored regimens. We’re starting to see the same level of precision in lymphedema care.”

In this conversation from Living Beyond Breast Cancer’s webinar, breast surgical oncologist Dr. Monique Gary explains why monitoring fluid changes matters — not just measuring an arm with a tape measure after swelling shows up.

The goal: identify fluid shifts early, understand a patient’s individual risk, and act before visible swelling and loss of function.

🎥 Watch the clip below.

02/25/2026

We're delighted to welcome Erik Anderson to the ImpediMed Board as an independent Non-Executive Director.

Erik is a proven US MedTech leader who spent over a decade at Hologic, Inc. (NASDAQ: HOLX), where he held multiple Division President roles — including leading the $1.6B+ Breast & Skeletal Health franchise, the company's largest business unit.

His appointment is a strong signal of our commitment to growth across three fronts:

- Cancer Survivorship — Erik led the global market leader in breast screening and diagnostics, giving him deep relationships across the oncology and breast cancer survivorship ecosystem where our BCRL solution is making a real difference for patients.
- Body Composition — Hologic's Skeletal Health business includes DXA, one of the most established measures of body composition, while his leadership of Cynosure brought body contouring and wellness technologies into the MedSpa channel. This experience is directly relevant as we expand SOZO into body composition monitoring.
- US Commercial Ex*****on — With 16+ years working with US hospital systems, IDN procurement leaders, and clinical champions, Erik brings the relationships and playbook to accelerate our growth across BCRL, body composition, and heart health.

In Erik's words: "I see enormous growth potential — not just in lymphedema, where the clinical evidence and guideline support are compelling, but across survivorship care and into heart health and body composition."

We couldn't agree more. Welcome to the team, Erik.

Read the full ASX announcement: https://investors.impedimed.com/announcements/7396928

02/21/2026

What is BIS—and why does it matter for cancer survivorship?

Bioimpedance spectroscopy (BIS) is the only noninvasive, low-cost technology that can detect medically significant fluid shifts before symptoms appear.

It’s how SOZO® detects subclinical lymphedema and other key health indicators —and supports early intervention that works.

✔️ Detects as little as 36 mL (two tablespoons) of fluid
✔️ Linked to 92% reduction in progression to chronic lymphedema when paired with compression
✔️ Also supports body composition analysis to support survivorship care

Swipe through to see how BIS works—and why it’s changing the standard of care.

Learn more: https://www.impedimed.com/resources/bis-technology/

02/19/2026

Early detection works best when it’s built into care.

In oncology, identifying risk is only the first step. What matters next is whether teams have a structured way to monitor, intervene, and follow patients over time.

That’s where programmatic approaches come in.

The Lymphedema Prevention Program (LPP) helps care teams operationalize early detection—embedding screening and monitoring into routine workflows, rather than relying on ad hoc checks or patient-reported symptoms alone.

It’s a practical way to support consistent, proactive care—without adding unnecessary burden to already complex programs.

Explore how teams operationalize early detection.
🔗 Learn more about the Lymphedema Prevention Program: https://www.impedimed.com/products/programs/lymphedema-prevention-program/

02/14/2026

During Heart Failure Awareness Week, it’s worth looking at what early risk actually looks like in practice.

In one case study, an 87-year-old patient with NYHA II–III heart failure was monitored following discharge.

Despite periods of apparent clinical stability, HF-Dex® remained elevated (>51%) for nearly 100 days—aligning with two subsequent hospital readmissions.

During that same period, weight remained largely unchanged.

The signal wasn’t visible on the scale. It was visible in extracellular fluid.

This is the difference between monitoring change and understanding risk.

See how fluid insights supported earlier detection of decompensation in this case.

🔗 Explore Heart Health Management https://www.impedimed.com/heart-health-management/

02/12/2026

In heart failure, congestion doesn’t always announce itself.

Extracellular fluid (ECF) can increase gradually—well before symptoms worsen or weight begins to change.

That’s why monitoring ECF offers a more direct view into fluid dynamics and decompensation risk. It reflects what’s happening physiologically, not just what shows up on the scale.

HF-Dex® translates these fluid shifts into a clear, objective signal—helping care teams identify rising risk earlier and intervene sooner.

Learn how ECF insights support proactive heart failure management.

🔗 Explore Heart Health Management https://www.impedimed.com/heart-health-management/

02/09/2026

This week marks the start of Heart Failure Awareness Week in the U.S.

In heart failure care, rising risk often shows up before symptoms worsen or weight changes.

Fluid can accumulate quietly—while patients appear stable and traditional monitoring suggests little has changed.

Tools like HF-Dex® are designed to surface those changes earlier, giving care teams clearer insight into readmission risk and more time to intervene.

Learn how heart failure programs are using fluid intelligence to support earlier, more proactive care.

🔗 https://www.impedimed.com/heart-health-management/

02/07/2026

February is Heart Health Month ❤️

Heart health is about more than a single number.

Today, care teams are looking at the body more holistically—using insights like fluid balance and body composition to better understand changes over time and support informed care.

Throughout Heart Health Month, we’ll be sharing how modern monitoring is helping shape the future of heart health.

https://www.impedimed.com/heart-health-management/

02/04/2026

Today is World Cancer Day, a global initiative led by the Union for International Cancer Control.

This year’s campaign theme, , puts people — not diagnoses — at the center of cancer care.

The message is simple: every experience of cancer is different, and care systems should reflect that.

Around the world, clinicians, advocates, survivors, and caregivers are sharing their stories to push for more people-centred, compassionate, and equitable care — during treatment and long after it ends.

Learn more about the United by Unique campaign and the global impact of World Cancer Day here: 🔗 https://www.worldcancerday.org/

01/28/2026

Exercise is widely recognized as beneficial in cancer care—but it’s still too often treated as a recommendation rather than a prescription.

In a recent MedCity News article, Maureen McBeth explores why movement needs to become a standard, structured part of cancer treatment and survivorship—not a wellness add-on—and what’s missing to make that shift possible.

The piece looks at the evidence, the implementation gap, and the role of personalized, data-informed approaches in supporting safe, effective exercise as part of care.

Read the full article here: https://www.impedimed.com/making-exercise-a-standard-in-cancer-survivorship-care/

01/23/2026

In a new piece for Physician’s Weekly, Steven Chen, MD, MBA argues that breast cancer care can’t stop at eliminating disease.

With more than 4 million people in the U.S. living after a breast cancer diagnosis, effective care means anticipating what comes next — including long-term physical effects, functional decline, and financial toxicity — from the very start of the care journey.

The article makes the case for moving from reactive to anticipatory care, with earlier conversations around survivorship risks, quality of life, and long-term health.

🔗 Read the full article here: https://www.impedimed.com/taking-charge-of-the-cost-conversation-practical-steps-for-patients-and-care-teams/

01/20/2026

January is often when care teams pause and reset.

It’s also a good time to revisit the basics:

- What does the SOZO® Digital Health Platform do?
- How does bioimpedance spectroscopy (BIS) work?
- What can patients expect from monitoring?

We pulled together the most common questions we hear and paired them with clear, straightforward answers.

Swipe to review the essentials — or visit the full FAQ page to learn more: https://www.impedimed.com/support/frequently-asked-questions/

Address

Carlsbad, CA
92008

Opening Hours

Monday	8am - 5pm
Tuesday	8am - 5pm
Wednesday	8am - 5pm
Thursday	8am - 5pm
Friday	8am - 5pm

Telephone

+17605852100

Website

http://www.impedimed.com/

Alerts

Be the first to know and let us send you an email when ImpediMed posts news and promotions. Your email address will not be used for any other purpose, and you can unsubscribe at any time.

Contact The Practice

Send a message to ImpediMed:

Shortcuts

Address
Telephone
Opening Hours
Alerts
Contact The Practice
Claim ownership or report listing

Want your practice to be the top-listed Clinic in Carlsbad?